← Eichor
Study identifier: NCT06261801 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of Electroacupuncture Combined With Pregabalin in the Treatment of Trigeminal Herpetic Neuralgia: a Multicenter Randomized Controlled Trial Study Protocol

Condition: Trigeminal Herpetic Neuralgia  ·  Sponsor: The Third People's Hospital of Hangzhou

PhaseNA
Planned participants102
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Trigeminal herpetic neuralgia is a common type of Zoster-associated Pain (ZAP), which troubles individuals in all ages and burdens society all over the world. Eleactroaupuncture (EA) is increasingly used in the treatment of ZAP due to its advantages such as low price, high safety, no adverse reactions, and high patient acceptance. Therefore, it is necessary to conduct randomized controlled trials to evaluate the effectiveness and safety of EA on ZAP and whether EA can be used as a substitute for pregabalin.

This description comes directly from the study's public registry record.

Talk to the study team

Pin Lin  ·  1358876268686  ·  yjlp1@163.com

Chengcheng Kong  ·  8613868078286  ·  njmukcc@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

The Hangzhou Third People's HospitalHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06261801